Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125923991 | 12592399 | 1 | I | 20160718 | 20160726 | 20160726 | PER | US-PFIZER INC-2016354117 | PFIZER | 0.00 | F | Y | 0.00000 | 20160726 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125923991 | 12592399 | 1 | PS | XANAX | ALPRAZOLAM | 1 | DAILY [2MG-6MG] [1ST TRIMESTER] | U | 18276 | ||||||||||
| 125923991 | 12592399 | 2 | SS | XANAX | ALPRAZOLAM | 1 | 1 MG, DAILY [2ND AND 3RD TRIMESTER] | U | 18276 | 1 | MG | ||||||||
| 125923991 | 12592399 | 3 | SS | XANAX | ALPRAZOLAM | 1 | 2 MG, DAILY [DURING BREASTFEEDING] | U | 18276 | 2 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125923991 | 12592399 | 1 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125923991 | 12592399 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125923991 | 12592399 | Drug dependence | |
| 125923991 | 12592399 | Intentional product misuse |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125923991 | 12592399 | 1 | 201604 | 0 | ||
| 125923991 | 12592399 | 2 | 201205 | 201210 | 0 | |
| 125923991 | 12592399 | 3 | 201210 | 201301 | 0 |